Anke Franzke
Overview
Explore the profile of Anke Franzke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zimmermann T, Dreismann L, Ginger V, Wenzel M, Hornemann B, Dietzsch F, et al.
J Cancer Res Clin Oncol
. 2022 Sep;
149(3):1343-1354.
PMID: 36166092
Purpose: Adequate, needs-oriented psycho-oncological care contributes to reducing psychological distress in cancer patients and their relatives and improving quality of life. Regarding the precise determination of objective and subjective needs,...
2.
Peters L, Brederecke J, Franzke A, de Zwaan M, Zimmermann T
Front Psychol
. 2020 Dec;
11:591771.
PMID: 33329254
Background: The diagnosis and treatment of cancer are associated with psychological distress that often leads to a significant reduction in emotional and physical well-being and quality of life. Early detection...
3.
Velaga S, Alter C, Dringenberg U, Thiesler C, Kuhs S, Olek S, et al.
Exp Hematol
. 2016 Oct;
45:27-35.e1.
PMID: 27693388
Recent clinical trials have indicated the high potential of regulatory T cells (Tregs) in the prevention of acute and chronic graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation, but immune...
4.
Velaga S, Ukena S, Dringenberg U, Alter C, Pardo J, Kershaw O, et al.
PLoS One
. 2015 May;
10(4):e0124927.
PMID: 25928296
In our previous work we could identify defects in human regulatory T cells (Tregs) likely favoring the development of graft-versus-host disease (GvHD) following allogeneic stem cell transplantation (SCT). Treg transcriptome...
5.
Henkenberens C, Franzke A, Raab P, Oschlies I, Klapper W, Christiansen H
Strahlenther Onkol
. 2014 May;
190(9):847-52.
PMID: 24823896
Background: Retrospective and prospective cohort studies suggest that central nervous system involvement occurs in approximately 0.5% of patients with advanced Hodgkin's lymphoma. The isolated primary intracranial manifestation of Hodgkin's lymphoma...
6.
Lammers S, Ukena S, Velaga S, Franzke A
Exp Clin Transplant
. 2013 Feb;
11(2):169-75.
PMID: 23432597
Objectives: The application of regulatory T cells in the field of solid-organ and hematopoietic stem cell transplantation is under investigation to develop novel cellular strategies for tolerance induction. Establishing in...
7.
Mueller-Loebnitz C, Ostermann H, Franzke A, Loeffler J, Uharek L, Topp M, et al.
Interdiscip Perspect Infect Dis
. 2013 Feb;
2013:102934.
PMID: 23401680
Patients with allogeneic stem cell transplantation (SCT) have a high risk of invasive fungal infections (IFIs) even after neutrophil regeneration. Immunological aspects might play a very important role in the...
8.
Ukena S, Velaga S, Goudeva L, Ivanyi P, Olek S, Falk C, et al.
PLoS One
. 2012 Dec;
7(12):e51644.
PMID: 23251603
Recent clinical studies demonstrate the high potency of regulatory T cells (Tregs) to control graft-versus-host disease in hematopoietic stem cell transplantation (SCT). However, the adoptive transfer of Tregs is limited...
9.
Velaga S, Ukena S, Hopting M, Ivanyi P, Borchers S, Mischak-Weissinger E, et al.
Immunol Invest
. 2012 Oct;
42(1):18-35.
PMID: 23083129
In experimental and clinical settings Tregs prevent graft-versus-host disease (GvHD) by inhibiting the proliferation and function of conventional T cells (Tconv). The suppressive potency of Tregs might also lead to...
10.
Ukena S, Geffers R, Buchholz S, Stadler M, Franzke A
Transpl Immunol
. 2012 Aug;
27(4):179-83.
PMID: 22889700
Despite improvements in the prevention and treatment of graft-versus-host disease (GvHD) this allogeneic immune response is still one of major complications following allogeneic stem cell transplantation (SCT). Identification of patients...